Timeline | Returns | Volume |
---|---|---|
Daily | 0.58% | 7,65,012 |
Weekly | -2.22% | 61,98,584 |
Monthly | -1.07% | 3,42,50,121 |
Timeline | Daily | Weekly | Monthly |
---|---|---|---|
PEL | 0.58% | -2.22% | -1.07% |
Index | -1.15% | 0.41% | -0.01% |
Peer Avg. | 0.52% | 3.38% | 3.55% |
Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
---|---|---|---|---|---|---|
PEL | 59.17 | 1.86 | 8.48 | 3.17 | 6.24 | 3.94 |
Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
Peer Avg. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Metrics | Sales Growth | Profit Growth | ROE | ROCE |
---|---|---|---|---|
FY '21-22 | 15.61% | 300.65% | 3.17 | 6.24 |
FY '20-21 | -5.67% | 99.13% | 1.40 | 6.60 |
FY '19-20 | -23.14% | -52.16% | -2.08 | 6.83 |
Metrics | Sales | Expenditure | EBITDA | PAT |
---|---|---|---|---|
FY '21-22 | 8,109.49 | 4,400.44 | 4,302.86 | 959.09 |
FY '20-21 | 7,317.02 | 3,082.55 | 4,559.31 | 477.11 |
FY '19-20 | 7,540.59 | 3,768.20 | 4,393.06 | -578.81 |
Metrics | Sales | Expenditure | EBITDA | PAT |
---|---|---|---|---|
PEL | 8,109.49 | 4,400.44 | 4,302.86 | 959.09 |
ENDURANCE | 6,623.11 | 5,776.47 | 879.36 | 421.23 |
NAVINFLUOR | 1,428.48 | 1,073.37 | 393.46 | 264.75 |
Piramal Enterprises Limited (PEL) is an Indian company engaged in diversified business activities such as financial services and pharmaceuticals. PEL Financial Services offers a range of financial products and solutions, including wholesale and retail financing. Wholesale loan agreements provide financing to real estate and businesses. In the field of retail lending, PEL builds a multi-product platform and offers its customers housing loans, small business loans and working capital loans. The company offers India Resurgence Fund (IndiaRF), a distressed investment investment platform that invests in equity and/or debt in non-real estate sectors. His financial services also include alternative assets and investments in the Shriram Group. PEL has a differentiated business model divided into three segments: Contract Development and Manufacturing Organization (CDMO), Complex Hospital Generic (CHG) and Consumer Healthcare India.